These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1775249)

  • 1. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
    Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
    Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay.
    Suen KK; Lewis WH; Lai KN
    Scand J Urol Nephrol; 1997 Jun; 31(3):289-93. PubMed ID: 9249895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
    J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-chain ratio of serum IgA1 in IgA nephropathy.
    Chui SH; Lam CW; Lewis WH; Lai KN
    J Clin Immunol; 1991 Jul; 11(4):219-23. PubMed ID: 1918269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN; To WY; Li PK; Leung JC
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant synthesis of IgA with lambda light chain in IgA nephropathy.
    Lai KN; Chui SH; Lai FM; Lam CW
    Kidney Int; 1988 Feb; 33(2):584-9. PubMed ID: 3129610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA.
    van den Wall Bake AW; Daha MR; Evers-Schouten J; van Es LA
    Am J Kidney Dis; 1988 Nov; 12(5):410-4. PubMed ID: 3189325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
    van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
    Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.
    Lai KN; Chan KW; Mac-Moune F; Ho CP; Yan KW; Lam CW; Vallance-Owen J
    Am J Clin Pathol; 1986 May; 85(5):548-51. PubMed ID: 3085470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge distribution of IgA-lambda in IgA nephropathy.
    Lai KN; Chui SH; Lewis WH; Poon AS; Lam CW
    Nephron; 1994; 66(1):38-44. PubMed ID: 8107951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light chain composition of IgA in IgA nephropathy.
    Lai KN; Lai FM; Lo ST; Lam CW
    Am J Kidney Dis; 1988 May; 11(5):425-9. PubMed ID: 3130751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of polymeric lambda-IgA binding to leukocytes in IgA nephropathy.
    Lai KN; Chan LY; Tang SC; Tsang AW; Guo H; Tse KC; Yip T; Leung JC
    J Am Soc Nephrol; 2002 Sep; 13(9):2309-19. PubMed ID: 12191975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass.
    Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
    Nephrol Dial Transplant; 1993; 8(1):25-8. PubMed ID: 8381930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
    Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
    J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
    Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
    J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX; Zhao MH
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.
    Li G; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Gao R
    Dis Markers; 2019; 2019():9802839. PubMed ID: 31354895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal IgA in IgA nephropathy.
    Yasumoto Y; Suga T; Miura M; Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Ann Acad Med Singap; 1988 Jul; 17(3):427-30. PubMed ID: 3146241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.